NeuroPace Q2 EPS $(0.36) Beats $(0.46) Estimate, Sales $16.51M Beat $12.62M Estimate
Portfolio Pulse from totan@benzinga.com
NeuroPace (NASDAQ:NPCE) reported Q2 earnings per share of $(0.36), beating the analyst consensus estimate of $(0.46) by 21.74%. The company also reported quarterly sales of $16.51 million, surpassing the analyst consensus estimate of $12.62 million by 30.82%. Both figures represent significant increases over the same period last year.
August 08, 2023 | 8:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NeuroPace's Q2 earnings and sales beat estimates, indicating a positive financial performance.
NeuroPace's Q2 earnings and sales exceeded analyst estimates, which is typically a positive signal for the company's financial health and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100